Example: Heart Attack

Clinical Trials Sponsored by CellMed AG, a subsidiary of BTG plc

Total 4 results

NCT01298830

Terminated

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Conditions: Intracerebral Hemorrhage (ICH)
NCT01196728

Completed

Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes

Conditions: Type II Diabetes Mellitus
NCT01165502

Completed

Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers

Conditions: Healthy
NCT01028521

Completed

First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of CM3.1-AC100

Conditions: Healthy